Safety of simultaneous vs sequential mRNA COVID-19 and inactivated influenza vaccines
1. In this randomized clinical trial, the safety profile, including reactogenicity, was similar...
Read MoreNov 18, 2024
1. In this randomized clinical trial, the safety profile, including reactogenicity, was similar...
Read MoreNov 17, 2024
1. In this randomized clinical trial comparing the use of pelvic floor muscle training (PFMT)...
Read MoreNov 16, 2024
1. In this prospective cohort of patients with acute myocardial infarction (AMI), plasma...
Read MoreNov 15, 2024
1. In this pilot randomized controlled trial, the Sleep Mood Intervention: Life Effectively...
Read MoreNov 12, 2024
1. The median progression-free survival was 15.0 months in the inavolisib and 7.3 months in the...
Read MoreNov 11, 2024
1. Suboptimal carbohydrate consumption is negatively associated with male fertility but not female...
Read MoreNov 10, 2024
1. 72-hour delayed serum sample processing had no effect on testing for cytokines, chemokines,...
Read MoreNov 9, 2024
1. Hydroxychloroquine significantly improves the lipid profile in patients with rheumatoid...
Read MoreNov 8, 2024
1. The MRI Assessment of the Causes of intracerebral hemorrhage (MACRO) score shows greater...
Read MoreNov 2, 2024
1. 5-year progression-free survival was increased in the induction chemotherapy group compared to...
Read MoreNov 1, 2024
1. Mean reduction in home systolic blood pressure at 12 weeks was greater with GMRx2 than with...
Read MoreOct 31, 2024
1. No significant difference was seen regarding progression-free survival between the...
Read MoreOct 31, 2024
1. The use of glucagon-like peptide 1 (GLP-1) agonists in patients with inflammatory bowel disease...
Read MoreOct 30, 2024
1. 36-month overall survival was significantly greater in the pembrolizumab-chemoradiotherapy...
Read MoreOct 29, 2024
1. The use of glucagon-like peptide 1 (GLP-1) receptor agonists in adults with type 2 diabetes...
Read MoreOct 25, 2024
1. Increased levels of hypersensitive C-reactive protein was associated with increased risk of non-alcoholic fatty liver disease among non-obese individuals. Evidence Rating Level: 3 (Average) Non-alcoholic fatty liver disease...
Read MoreOct 24, 2024
1. Half of patients visiting the emergency department for acute migraine could have been diagnosed...
Read MoreOct 23, 2024
1. Males with lupus nephritis had higher all-cause mortality and proportion of infection-related...
Read MoreOct 19, 2024
1. Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients...
Read MoreOct 18, 2024
1. 36-month overall survival and median event-free survival were significantly greater in the...
Read More